Halozyme Therapeutics, Inc.
2020 Q2 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/5/2026 | 82,353 | 1.1% | 1,223,665 | 12/31/2025 |
| 2025 Q3 | 10/28/2025 | 89,855 | 1.2% | 1,225,181 | 9/30/2025 |
| 2025 Q2 | 7/30/2025 | 67,209 | 0.9% | 1,291,977 | 6/30/2025 |
| 2025 Q1 | 5/1/2025 | 85,312 | 1.2% | 1,336,974 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 64,398 | 0.9% | 1,346,957 | 12/31/2024 |
| 2024 Q3 | 10/28/2024 | 77,831 | 1.1% | 1,359,730 | 9/30/2024 |
| 2024 Q2 | 8/6/2024 | 74,451 | 1.0% | 1,421,904 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 62,918 | 0.8% | 1,546,666 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 56,122 | 0.8% | 1,518,455 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 55,570 | 0.9% | 1,454,707 | 9/30/2023 |
| 2023 Q2 | 8/15/2023 | 48,302 | 0.8% | 1,339,122 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 49,913 | 0.8% | 1,306,970 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 73,734 | 1.3% | 1,294,025 | 12/31/2022 |
| 2022 Q3 | 11/7/2022 | 51,360 | 1.0% | 1,298,934 | 9/30/2022 |
| 2022 Q2 | 8/3/2022 | 57,375 | 1.1% | 1,303,983 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 51,642 | 0.8% | 1,294,937 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 51,255 | 0.7% | 1,274,679 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 51,683 | 0.7% | 1,270,480 | 9/30/2021 |
| 2021 Q2 | 8/9/2021 | 49,849 | 0.7% | 1,097,754 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 45,590 | 0.7% | 1,093,538 | 3/31/2021 |
| 2020 Q4 | 2/10/2021 | 41,608 | 0.6% | 974,207 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 7,067 | 0.1% | 268,898 | 9/30/2020 |
| 2020 Q2 | 8/24/2020 | 4,672 | 0.1% | 174,275 | 6/30/2020 |